Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primulagenin A is a potent inverse agonist of the nuclear receptor RAR-related orphan receptor gamma (ROR<i>γ</i>).

Acta pharmaceutica Sinica. B·2026
Same author

Lanostane-type triterpenoids from ethnomedicinal fungi inhibit endothelial cell proliferation.

Journal of ethnopharmacology·2026
Same author

Correction: Natural pigments from the endophyte Aspergillus westerdijkiae and evaluation of their bioactivities.

Microbial cell factories·2026
Same author

Miquelianin and spiraeoside from <i>Filipendula ulmaria</i> mitigate α-synuclein accumulation in <i>C.elegans</i> and reduce the expression of neuroinflammatory cytokines in human microglia.

Frontiers in pharmacology·2026
Same author

Natural pigments from the endophyte Aspergillus westerdijkiae and evaluation of their bioactivities.

Microbial cell factories·2025
Same author

Bilberry (Vaccinium myrtillus L.) Peel-Enriched Pomace as Natural Anticancer Agents: Preclinical Evidence from Breast Carcinoma Models Supporting Preventive and Personalized Treatment Strategies.

The Journal of nutrition·2025
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Computational techniques for lead discovery from nature

Judith M Rollinger

    Current Pharmaceutical Design
    |April 10, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
    14:34

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

    Published on: April 3, 2026

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    09:19

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

    Published on: June 4, 2021

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
    06:26

    Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

    Published on: May 16, 2021

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
    14:34

    A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

    Published on: April 3, 2026

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
    09:19

    NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

    Published on: June 4, 2021